Israel - Tiếng Do Thái - Ministry of Health

david margalit & co.ltd - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.05 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

david margalit & co.ltd - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.1 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

david margalit & co.ltd - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.2 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

david margalit & co.ltd - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.5 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

easy care ltd, israel - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.1 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

easy care ltd, israel - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.2 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

easy care ltd, israel - octreotide as acetate - תמיסה להזרקה - octreotide as acetate 0.5 mg/ml - octreotide

Israel - Tiếng Do Thái - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Tiếng Do Thái - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Tiếng Do Thái - Ministry of Health

novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 20 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.